In vitro degradation and antitumor activity of oxime bond-linked daunorubicin-GnRH-III bioconjugates and DNA-binding properties of daunorubicin-amino acid metabolites (Q39643108)

From Wikidata

Jump to navigation Jump to search

scientific article published on 16 October 2010

Language	Label	Description	Also known as
English	In vitro degradation and antitumor activity of oxime bond-linked daunorubicin-GnRH-III bioconjugates and DNA-binding properties of daunorubicin-amino acid metabolites	scientific article published on 16 October 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

In vitro degradation and antitumor activity of oxime bond-linked daunorubicin-GnRH-III bioconjugates and DNA-binding properties of daunorubicin-amino acid metabolites (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

1

object named as

Erika Orbán

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

9

object named as

Marilena Manea

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

2

object named as

Gábor Mezo

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

author name string

Pascal Schlage

3

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Gabriella Csík

4

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Zarko Kulić

5

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Philipp Ansorge

6

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Erzsébet Fellinger

7

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Heiko Michael Möller

8

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

publication date

16 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

41

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

469-483

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Design, synthesis, and in vitro activity of novel drug delivery systems containing tuftsin derivatives and methotrexate.

1 reference

https://api.crossref.org/works/10.1007/S00726-010-0766-1

21 January 2018

Highly potent metallopeptide analogues of luteinizing hormone-releasing hormone.

1 reference

https://api.crossref.org/works/10.1007/S00726-010-0766-1

21 January 2018

Adriamycin(hydrazone)-antibody conjugates require internalization and intracellular acid hydrolysis for antitumor activity

1 reference

https://api.crossref.org/works/10.1007/S00726-010-0766-1

21 January 2018

Biophysical chemistry of the daunomycin-DNA interaction.

1 reference

https://api.crossref.org/works/10.1007/S00726-010-0766-1

21 January 2018

Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture

1 reference

https://api.crossref.org/works/10.1007/S00726-010-0766-1

21 January 2018

Design of a multivalent galactoside ligand for selective targeting of HPMA copolymer-doxorubicin conjugates to human colon cancer cells

1 reference

https://api.crossref.org/works/10.1007/S00726-010-0766-1

21 January 2018

Receptor-mediated and enzyme-dependent targeting of cytotoxic anticancer drugs

1 reference

https://api.crossref.org/works/10.1007/S00726-010-0766-1

21 January 2018

Cathepsin B-labile dipeptide linkers for lysosomal release of doxorubicin from internalizing immunoconjugates: model studies of enzymatic drug release and antigen-specific in vitro anticancer activity

1 reference

https://api.crossref.org/works/10.1007/S00726-010-0766-1

21 January 2018

New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage: synthesis and preliminary in vitro and in vivo biological properties

1 reference

https://api.crossref.org/works/10.1007/S00726-010-0766-1

21 January 2018

The cardiotoxicity of adriamycin and daunomycin in children

1 reference

https://api.crossref.org/works/10.1007/S00726-010-0766-1

21 January 2018

Importance of the central region of lamprey gonadotropin-releasing hormone III in the inhibition of breast cancer cell growth.

1 reference

https://api.crossref.org/works/10.1007/S00726-010-0766-1

21 January 2018

Recent advances in tumor-targeting anticancer drug conjugates.

1 reference

https://api.crossref.org/works/10.1007/S00726-010-0766-1

21 January 2018

Structure elucidation and antifungal activity of an anthracycline antibiotic, daunomycin, isolated from Actinomadura roseola

1 reference

https://api.crossref.org/works/10.1007/S00726-010-0766-1

21 January 2018

Structure-activity study on the LH- and FSH-releasing and anticancer effects of gonadotropin-releasing hormone (GnRH)-III analogs

1 reference

https://api.crossref.org/works/10.1007/S00726-010-0766-1

21 January 2018

Targeted delivery of doxorubicin by HPMA copolymer-hyaluronan bioconjugates

1 reference

https://api.crossref.org/works/10.1007/S00726-010-0766-1

21 January 2018

Liberation of doxorubicin from HPMA copolymer conjugate is essential for the induction of cell cycle arrest and nuclear fragmentation in ovarian carcinoma cells

1 reference

https://api.crossref.org/works/10.1007/S00726-010-0766-1

21 January 2018

Theoretical aspects of DNA-protein interactions: co-operative and non-co-operative binding of large ligands to a one-dimensional homogeneous lattice.

1 reference

https://api.crossref.org/works/10.1007/S00726-010-0766-1

21 January 2018

Receptor-mediated tumor targeting based on peptide hormones

1 reference

https://api.crossref.org/works/10.1007/S00726-010-0766-1

21 January 2018

Structure, enzymatic stability and antitumor activity of sea lamprey GnRH-III and its dimer derivatives

1 reference

https://api.crossref.org/works/10.1007/S00726-010-0766-1

21 January 2018

New derivatives of GnRH as potential anticancer therapeutic agents

1 reference

https://api.crossref.org/works/10.1007/S00726-010-0766-1

21 January 2018

Secondary alcohol metabolites mediate iron delocalization in cytosolic fractions of myocardial biopsies exposed to anticancer anthracyclines. Novel linkage between anthracycline metabolism and iron-induced cardiotoxicity

1 reference

https://api.crossref.org/works/10.1007/S00726-010-0766-1

21 January 2018

Cytotoxic analogs of luteinizing hormone-releasing hormone containing doxorubicin or 2-pyrrolinodoxorubicin, a derivative 500-1000 times more potent

1 reference

https://api.crossref.org/works/10.1007/S00726-010-0766-1

21 January 2018

Stability of cytotoxic luteinizing hormone-releasing hormone conjugate (AN-152) containing doxorubicin 14-O-hemiglutarate in mouse and human serum in vitro: implications for the design of preclinical studies.

1 reference

https://api.crossref.org/works/10.1007/S00726-010-0766-1

21 January 2018

HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. II. Processing in epithelial ovarian carcinoma cells in vitro

1 reference

https://api.crossref.org/works/10.1007/S00726-010-0766-1

21 January 2018

Gonadotropin-releasing hormone analogue conjugates with strong selective antitumor activity

1 reference

https://api.crossref.org/works/10.1007/S00726-010-0766-1

21 January 2018

Synthesis and NMR spectral studies of some 2,6-diarylpiperidin-4-one O-benzyloximes

1 reference

https://api.crossref.org/works/10.1007/S00726-010-0766-1

21 January 2018

New approaches to treatment of various cancers based on cytotoxic analogs of LHRH, somatostatin and bombesin

1 reference

https://api.crossref.org/works/10.1007/S00726-010-0766-1

21 January 2018

Chemotherapy targeted to cancers through tumoral hormone receptors

1 reference

https://api.crossref.org/works/10.1007/S00726-010-0766-1

21 January 2018

Synthesis, characterization, and metabolic stability of porphyrin-peptide conjugates bearing bifunctional signaling sequences

1 reference

https://api.crossref.org/works/10.1007/S00726-010-0766-1

21 January 2018

Recent trends in targeted anticancer prodrug and conjugate design

1 reference

https://api.crossref.org/works/10.1007/S00726-010-0766-1

21 January 2018

Development of an oxime bond containing daunorubicin-gonadotropin-releasing hormone-III conjugate as a potential anticancer drug

1 reference

https://api.crossref.org/works/10.1007/S00726-010-0766-1

21 January 2018

An insight on hyaluronic acid in drug targeting and drug delivery

1 reference

https://api.crossref.org/works/10.1007/S00726-010-0766-1

21 January 2018

Endogenous lectins as targets for drug delivery

1 reference

https://api.crossref.org/works/10.1007/S00726-010-0766-1

21 January 2018

Identifiers

10.1007/S00726-010-0766-1

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39643108&oldid=2203051279"